Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome

References

• Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010; 6:322-9; PMID:20224296; http://dx.doi.org/10.4161/auto.6.3.11625
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011; 8:528-39; PMID:21587219; http://dx.doi.org/10.1038/nrclinonc.2011.71
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11:709-30; PMID:22935804; http://dx.doi.org/10.1038/nrd3802
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 2013; 4:e838; PMID:24113172; http://dx.doi.org/10.1038/cddis.2013.350
   PubMed Web of Science ®Google Scholar
• Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368:1845-6; PMID:23656658; http://dx.doi.org/10.1056/NEJMra1205406
   PubMed Web of Science ®Google Scholar
• Rebecca VW, Amaravadi RK. Emerging strategies to effectively target autophagy in cancer. Oncogene 2016; 35:1–11; PMID:25893285; http://dx.doi.org/10.1038/onc.2015.99
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, Bussink J, Geurts-Moespot A, Sweep FC, Span PN. Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy. Semin Cancer Biol 2015; 31:99-105; PMID:24933034; http://dx.doi.org/10.1016/j.semcancer.2014.06.001
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, Nixon C, Liu E, Mah LY, Ryan KM. Analysis of macroautophagy by immunohistochemistry. Autophagy 2012; 8:963-9; PMID:22562096; http://dx.doi.org/10.4161/auto.20186
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12:1-222; PMID:26799652; http://dx.doi.org/10.1080/15548627.2015.1100356
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j.cell.2010.01.028
   PubMed Web of Science ®Google Scholar
• Barth S, Glick D, Macleod KF. Autophagy: assays and artifacts. J Pathol 2010; 221:117-24; PMID:20225337; http://dx.doi.org/10.1002/path.2694
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Chen S, Huang KX, Le WD. Why should autophagic flux be assessed? Acta Pharmacol Sin 2013; 34:595-9; PMID:23474710; http://dx.doi.org/10.1038/aps.2012.184
   PubMed Web of Science ®Google Scholar
• Ma XH, Piao S, Wang D, McAfee QW, Nathanson KL, Lum JJ, Li LZ, Amaravadi RK. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res 2011; 17:3478-89; PMID:21325076; http://dx.doi.org/10.1158/1078-0432.CCR-10-2372
   PubMed Web of Science ®Google Scholar
• do Amaral JB, Rezende-Teixeira P, Freitas VM, Machado-Santelli GM. MCF-7 cells as a three-dimensional model for the study of human breast cancer. Tissue Eng Part C Methods 2011; 17:1097-107; PMID:21882900; http://dx.doi.org/10.1089/ten.tec.2011.0260
   PubMed Web of Science ®Google Scholar
• Gomes LR, Vessoni AT, Menck CF. Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy. Oncogene 2015; 34:5329–40; PMID: 25619836; http://dx.doi.org/10.1038/onc.2014.461
   Web of Science ®Google Scholar
• Kim KU, Wilson SM, Abayasiriwardana KS, Collins R, Fjellbirkeland L, Xu Z, Jablons DM, Nishimura SL, Broaddus VC. A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am J Respir Cell Mol Biol 2005; 33:541-8; PMID:16123394; http://dx.doi.org/10.1165/rcmb.2004-0355OC
   PubMed Web of Science ®Google Scholar
• Wilson SM, Barbone D, Yang TM, Jablons DM, Bueno R, Sugarbaker DJ, Nishimura SL, Gordon GJ, Broaddus VC. mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. Am J Respir Cell Mol Biol 2008; 39:576-83; PMID:18511708; http://dx.doi.org/10.1165/rcmb.2007-0460OC
   PubMed Web of Science ®Google Scholar
• Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res 2009; 69:1570-7; PMID:19221091; http://dx.doi.org/10.1158/0008-5472.CAN-08-1363
   PubMed Web of Science ®Google Scholar
• Barbone D, Cheung P, Battula S, Busacca S, Gray SG, Longley DB, Bueno R, Sugarbaker DJ, Fennell DA, Broaddus VC. Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One 2012; 7:e52753; PMID:23300762; http://dx.doi.org/10.1371/journal.pone.0052753
   PubMed Web of Science ®Google Scholar
• Lee YJ, Hah YJ, Kang YN, Kang KJ, Hwang JS, Chung WJ, Cho KB, Park KS, Kim ES, Seo HY, et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS One 2013; 8:e81540; PMID:24282606; http://dx.doi.org/10.1371/journal.pone.0081540
   PubMed Web of Science ®Google Scholar
• Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L, Lan Q, Zhang W, Ji D, Wu J, et al. Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer. PLoS One 2013; 8:e80338; PMID:24260370; http://dx.doi.org/10.1371/journal.pone.0080338
   PubMed Web of Science ®Google Scholar
• Cai M, Hu Z, Liu J, Gao J, Liu C, Liu D, Tan M, Zhang D, Lin B. Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int J Mol Sci 2014; 15:5292-303; PMID:24675697; http://dx.doi.org/10.3390/ijms15045292
   PubMed Web of Science ®Google Scholar
• Choi JH, Cho YS, Ko YH, Hong SU, Park JH, Lee MA. Absence of autophagy-related proteins expression is associated with poor prognosis in patients with colorectal adenocarcinoma. Gastroenterol Res Pract 2014; 2014:179586; PMID:24723943; http://dx.doi.org/10.1155/2014/179586
   PubMed Web of Science ®Google Scholar
• Qiu DM, Wang GL, Chen L, Xu YY, He S, Cao XL, Qin J, Zhou JM, Zhang YX, E Q. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. BMC Cancer 2014; 14:327; PMID:24885292; http://dx.doi.org/10.1186/1471-2407-14-327
   PubMed Web of Science ®Google Scholar
• Winardi D, Tsai HP, Chai CY, Chung CL, Loh JK, Chen YH, Hsieh CL. Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma. Biomed Res Int 2014; 2014:723176; PMID:24900981
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y, Zheng HC. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma. Tumour Biol 2014; 35:1955-64; PMID:24132590; http://dx.doi.org/10.1007/s13277-013-1261-6
   PubMed Web of Science ®Google Scholar
• Yang M, Zhao H, Guo L, Zhang Q, Zhao L, Bai S, Zhang M, Xu S, Wang F, Wang X, et al. Autophagy-based survival prognosis in human colorectal carcinoma. Oncotarget 2015; 6:7084-103; PMID:25762626; http://dx.doi.org/10.18632/oncotarget.3054
   PubMed Web of Science ®Google Scholar
• Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci 2015; 106:1-8; PMID:25338734; http://dx.doi.org/10.1111/cas.12559
   PubMed Web of Science ®Google Scholar
• Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, et al. Decreased mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. EBioMedicine 2015; 2:255-63; http://dx.doi.org/10.1016/j.ebiom.2015.01.008
   PubMed Web of Science ®Google Scholar
• Yang Z, Ghoorun RA, Fan X, Wu P, Bai Y, Li J, Chen H, Wang L, Wang J. High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer. Clin Res Hepatol Gastroenterol 2015; 39:98-106; PMID:25130795; http://dx.doi.org/10.1016/j.clinre.2014.06.014
   PubMed Web of Science ®Google Scholar
• Alers S, Loffler AS, Paasch F, Dieterle AM, Keppeler H, Lauber K, Campbell DG, Fehrenbacher B, Schaller M, Wesselborg S, et al. Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy 2011; 7:1423-33; PMID:22024743; http://dx.doi.org/10.4161/auto.7.12.18027
   PubMed Web of Science ®Google Scholar
• Alers S, Wesselborg S, Stork B. ATG13: just a companion, or an executor of the autophagic program? Autophagy 2014; 10:944-56; PMID:24879146; http://dx.doi.org/10.4161/auto.28987
   PubMed Web of Science ®Google Scholar
• Kaizuka T, Mizushima N. Atg13 is essential for autophagy and cardiac development in mice. Mol Cell Biol 2015; 36(4):585-95; PMID:26644405
   PubMed Web of Science ®Google Scholar
• Karanasios E, Stapleton E, Manifava M, Kaizuka T, Mizushima N, Walker SA, Ktistakis NT. Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J Cell Sci 2013; 126:5224-38; PMID:24013547; http://dx.doi.org/10.1242/jcs.132415
   PubMed Web of Science ®Google Scholar
• Barbone D, Follo C, Echeverry N, Gerbaudo VH, Klabatsa A, Bueno R, Felley-Bosco E, Broaddus VC. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS One 2015; 10:e0134825; PMID:26284517; http://dx.doi.org/10.1371/journal.pone.0134825
   PubMedGoogle Scholar
• Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994; 86:829-35; PMID:8182763; http://dx.doi.org/10.1093/jnci/86.11.829
   PubMed Web of Science ®Google Scholar
• Nicotra G, Mercalli F, Peracchio C, Castino R, Follo C, Valente G, Isidoro C. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 2010; 23:937-50; PMID:20473282; http://dx.doi.org/10.1038/modpathol.2010.80
   PubMed Web of Science ®Google Scholar
• Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 2012; 18:370-9; PMID:22080440; http://dx.doi.org/10.1158/1078-0432.CCR-11-1282
   PubMed Web of Science ®Google Scholar
• Chen S, Jiang YZ, Huang L, Zhou RJ, Yu KD, Liu Y, Shao ZM. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy. Clin Cancer Res 2013; 19:6853-62; PMID:24141623; http://dx.doi.org/10.1158/1078-0432.CCR-13-1617
   PubMed Web of Science ®Google Scholar
• Sakurai T, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Omoto I, Owaki T, Maemura K, Ishigami S, Natsugoe S. The expression of LC-3 is related to tumor suppression through angiogenesis in esophageal cancer. Med Oncol 2013; 30:701; PMID:24122254; http://dx.doi.org/10.1007/s12032-013-0701-x
   PubMed Web of Science ®Google Scholar
• Tang JY, Hsi E, Huang YC, Hsu NC, Chen YK, Chu PY, Chai CY. ATG9A overexpression is associated with disease recurrence and poor survival in patients with oral squamous cell carcinoma. Virchows Arch 2013; 463:737-42; PMID:24085552; http://dx.doi.org/10.1007/s00428-013-1482-5
   PubMed Web of Science ®Google Scholar
• Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, Chai CY. High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 2013; 44:2558-62; PMID:24055091; http://dx.doi.org/10.1016/j.humpath.2013.06.017
   PubMed Web of Science ®Google Scholar
• Lefort S, Joffre C, Kieffer Y, Givel AM, Bourachot B, Zago G, Bieche I, Dubois T, Meseure D, Vincent-Salomon A, et al. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers. Autophagy 2014; 10:2122-42; PMID:25427136; http://dx.doi.org/10.4161/15548627.2014.981788
   PubMed Web of Science ®Google Scholar
• Liu JL, Chen FF, Lung J, Lo CH, Lee FH, Lu YC, Hung CH. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma. Br J Cancer 2014; 111:944-54; PMID:24983366; http://dx.doi.org/10.1038/bjc.2014.355
   PubMed Web of Science ®Google Scholar
• Wu DH, Jia CC, Chen J, Lin ZX, Ruan DY, Li X, Lin Q, Min D, Ma XK, Wan XB, et al. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumour Biol 2014; 35:12225-33; PMID:25256671; http://dx.doi.org/10.1007/s13277-014-2531-7
   PubMed Web of Science ®Google Scholar
• Yun M, Bai HY, Zhang JX, Rong J, Weng HW, Zheng ZS, Xu Y, Tong ZT, Huang XX, Liao YJ, et al. ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma. PLoS One 2015; 10:e0117375; PMID:25714809; http://dx.doi.org/10.1371/journal.pone.0117375
   PubMedGoogle Scholar
• Gu Y, Li P, Peng F, Zhang M, Zhang Y, Liang H, Zhao W, Qi L, Wang H, Wang C, et al. Autophagy-related prognostic signature for breast cancer. Mol Carcinog 2016; 55:292–9; PMID: 25620657; http://dx.doi.org/10.1002/mc.22278
   Web of Science ®Google Scholar
• Jao CC, Ragusa MJ, Stanley RE, Hurley JH. A HORMA domain in Atg13 mediates PI 3-kinase recruitment in autophagy. Proc Natl Acad Sci U S A 2013; 110:5486-91; PMID:23509291; http://dx.doi.org/10.1073/pnas.1220306110
   PubMed Web of Science ®Google Scholar
• Cuzick J. Controversies in design and interpretation of adjuvant clinical trials. Cancer Invest 2010; 28 Suppl 1:28-34; PMID:20653405; http://dx.doi.org/10.3109/07357907.2010.501633
   PubMed Web of Science ®Google Scholar
• Hamai A, Codogno P, Mehrpour M. Cancer stem cells and autophagy: Facts and Perspectives. J Cancer Stem Cell Res 2014; 2:e1005; http://dx.doi.org/10.14343/JCSCR.2014.2e1005
   Google Scholar
• Cortes-Dericks L, Froment L, Boesch R, Schmid RA, Karoubi G. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. BMC Cancer 2014; 14:304; PMID:24884875; http://dx.doi.org/10.1186/1471-2407-14-304
   PubMed Web of Science ®Google Scholar
• Pasdar EA, Smits M, Stapelberg M, Bajzikova M, Stantic M, Goodwin J, Yan B, Stursa J, Kovarova J, Sachaphibulkij K, et al. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents. PLoS One 2015; 10:e0119549; PMID:25932953; http://dx.doi.org/10.1371/journal.pone.0119549
   PubMedGoogle Scholar
• Eskelinen EL. The dual role of autophagy in cancer. Curr Opin Pharmacol 2011; 11:294-300; PMID:21498118; http://dx.doi.org/10.1016/j.coph.2011.03.009
   PubMed Web of Science ®Google Scholar
• Liu B, Wen X, Cheng Y. Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death Dis 2013; 4:e892; PMID:24176850; http://dx.doi.org/10.1038/cddis.2013.422
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, et al. Autophagy in malignant transformation and cancer progression. EMBO J 2015; 34:856-80; PMID:25712477; http://dx.doi.org/10.15252/embj.201490784
   PubMed Web of Science ®Google Scholar
• Denton D, Xu T, Kumar S. Autophagy as a pro-death pathway. Immunol Cell Biol 2015; 93:35-42; PMID:25331550; http://dx.doi.org/10.1038/icb.2014.85
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest 2015; 125:42-6; PMID:25654549; http://dx.doi.org/10.1172/JCI73941
   PubMed Web of Science ®Google Scholar
• Sharma K, Le N, Alotaibi M, Gewirtz DA. Cytotoxic autophagy in cancer therapy. Int J Mol Sci 2014; 15:10034-51; PMID:24905404; http://dx.doi.org/10.3390/ijms150610034
   PubMed Web of Science ®Google Scholar
• Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ 2015; 22:367-76; PMID:25257169; http://dx.doi.org/10.1038/cdd.2014.143
   PubMed Web of Science ®Google Scholar
• Echeverry N, Ziltener G, Barbone D, Weder W, Stahel RA, Broaddus VC, Felley-Bosco E. Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death Dis 2015; 6:e1757; PMID:25950487; http://dx.doi.org/10.1038/cddis.2015.124
   PubMedGoogle Scholar
• Harasawa R, Mizusawa H, Nozawa K, Nakagawa T, Asada K, Kato I. Detection and tentative identification of dominant mycoplasma species in cell cultures by restriction analysis of the 16S-23S rRNA intergenic spacer regions. Res Microbiol 1993; 144:489-93; PMID:7910696; http://dx.doi.org/10.1016/0923-2508(93)90057-9
   PubMed Web of Science ®Google Scholar
• Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 2008; 283:13021-30; PMID:18339627; http://dx.doi.org/10.1074/jbc.M709698200
   PubMed Web of Science ®Google Scholar